These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12957235)

  • 1. Chronic opioid antagonist treatment dose-dependently regulates mu-opioid receptors and trafficking proteins in vivo.
    Rajashekara V; Patel CN; Patel K; Purohit V; Yoburn BC
    Pharmacol Biochem Behav; 2003 Jul; 75(4):909-13. PubMed ID: 12957235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic opioid antagonist treatment selectively regulates trafficking and signaling proteins in mouse spinal cord.
    Patel CN; Rajashekara V; Patel K; Purohit V; Yoburn BC
    Synapse; 2003 Oct; 50(1):67-76. PubMed ID: 12872295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous opioid agonist treatment dose-dependently regulates mu-opioid receptors and dynamin-2 in mouse spinal cord.
    Zhang Q; Purohit V; Yoburn BC
    Synapse; 2005 Jun; 56(3):123-8. PubMed ID: 15765525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo.
    Patel MB; Patel CN; Rajashekara V; Yoburn BC
    Mol Pharmacol; 2002 Dec; 62(6):1464-70. PubMed ID: 12435815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC; Purohit V; Patel K; Zhang Q
    Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu-opioid receptor up-regulation and functional supersensitivity are independent of antagonist efficacy.
    Sirohi S; Kumar P; Yoburn BC
    J Pharmacol Exp Ther; 2007 Nov; 323(2):701-7. PubMed ID: 17698975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity.
    Lee SC; Yoburn BC
    Pharmacol Biochem Behav; 2000 Jun; 66(2):347-51. PubMed ID: 10880689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.
    Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment.
    Narita M; Mizoguchi H; Nagase H; Suzuki T; Tseng LF
    Brain Res; 2001 Sep; 913(2):170-3. PubMed ID: 11549382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
    Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
    Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid antagonist-induced receptor upregulation: effects of concurrent agonist administration.
    Yoburn BC; Duttaroy A; Shah S; Davis T
    Brain Res Bull; 1994; 33(2):237-40. PubMed ID: 8275346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of mu-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation.
    Shah S; Duttaroy A; Chen BT; Carroll J; Yoburn BC
    Brain Res Bull; 1997; 42(6):479-84. PubMed ID: 9128924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid receptor regulation in mice.
    Yoburn BC; Billings B; Duttaroy A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonist-induced micro-opioid receptor up-regulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cord.
    Patel M; Gomes B; Patel C; Yoburn BC
    Eur J Pharmacol; 2002 Jun; 446(1-3):37-42. PubMed ID: 12098583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic opioid antagonist treatment: assessment of receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Eur J Pharmacol; 1989 Nov; 170(3):193-200. PubMed ID: 2559854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity.
    Yoburn BC; Shah S; Chan K; Duttaroy A; Davis T
    Pharmacol Biochem Behav; 1995; 51(2-3):535-9. PubMed ID: 7667382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons.
    Walwyn WM; Wei W; Xie CW; Chiu K; Kieffer BL; Evans CJ; Maidment NT
    Neuroscience; 2006 Oct; 142(2):493-503. PubMed ID: 16887280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.